HU197212B - Process for producing pharmaceuticals with antiviral and antitumour effect - Google Patents

Process for producing pharmaceuticals with antiviral and antitumour effect Download PDF

Info

Publication number
HU197212B
HU197212B HU863351A HU335186A HU197212B HU 197212 B HU197212 B HU 197212B HU 863351 A HU863351 A HU 863351A HU 335186 A HU335186 A HU 335186A HU 197212 B HU197212 B HU 197212B
Authority
HU
Hungary
Prior art keywords
sodium
acid
xanthate
potassium
adjuvant
Prior art date
Application number
HU863351A
Other languages
German (de)
English (en)
Hungarian (hu)
Other versions
HUT42949A (en
Inventor
Gerhard Sauer
Eberhard Amtmann
Klaus W Hummel
Original Assignee
Merz & Co Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz & Co Gmbh & Co filed Critical Merz & Co Gmbh & Co
Publication of HUT42949A publication Critical patent/HUT42949A/hu
Publication of HU197212B publication Critical patent/HU197212B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HU863351A 1985-08-02 1986-08-01 Process for producing pharmaceuticals with antiviral and antitumour effect HU197212B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3527871 1985-08-02

Publications (2)

Publication Number Publication Date
HUT42949A HUT42949A (en) 1987-09-28
HU197212B true HU197212B (en) 1989-03-28

Family

ID=6277597

Family Applications (1)

Application Number Title Priority Date Filing Date
HU863351A HU197212B (en) 1985-08-02 1986-08-01 Process for producing pharmaceuticals with antiviral and antitumour effect

Country Status (7)

Country Link
KR (1) KR860008777A (es)
AT (1) AT388499B (es)
CS (1) CS275793B6 (es)
DD (1) DD286971A5 (es)
ES (1) ES2000384A6 (es)
HU (1) HU197212B (es)
PT (1) PT83127B (es)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1140M (fr) * 1961-05-16 1962-02-19 Johnson & Johnson Composition chimiothérapique a efficacité accrue.
US4164573A (en) * 1975-06-13 1979-08-14 Galinsky Alvin M Composition and method for making a suppository for introducing a hypoglycemic agent into a mammal
IT1202370B (it) * 1976-07-12 1989-02-09 Hoffmann La Roche Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
JPS5940137B2 (ja) * 1976-10-14 1984-09-28 武田薬品工業株式会社 経口投与用医薬組成物
JPS54122719A (en) * 1978-03-16 1979-09-22 Sankyo Co Ltd Carcinostatic agent for oral administration
JPS56100711A (en) * 1980-01-16 1981-08-12 Teijin Ltd Pharmaceutical for remedy of uterine cancer
CA1174978A (en) * 1980-11-26 1984-09-25 Arthur Scherm Xanthates
AR230264A1 (es) * 1980-11-26 1984-03-01 Merz & Co Gmbh & Co Procedimiento para la obtencion de compuestos de xantato
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
JPS58124714A (ja) * 1982-01-20 1983-07-25 Yamanouchi Pharmaceut Co Ltd 抗腫瘍物質の油性組成物
DE3218121A1 (de) * 1982-05-14 1983-11-17 Leskovar, Peter, Dr.-Ing., 8000 München Arzneimittel zur tumorbehandlung

Also Published As

Publication number Publication date
HUT42949A (en) 1987-09-28
ATA208786A (de) 1988-12-15
CS8605798A2 (en) 1990-10-12
KR860008777A (ko) 1986-12-18
ES2000384A6 (es) 1991-03-16
DD286971A5 (de) 1991-02-14
PT83127A (en) 1986-09-01
PT83127B (pt) 1989-03-30
CS275793B6 (en) 1992-03-18
AT388499B (de) 1989-06-26

Similar Documents

Publication Publication Date Title
US8138200B2 (en) Compositions and methods for double-targeting virus infections and targeting cancer cells
US20200054552A1 (en) Medicament for the treatment of viral skin and tumour diseases
PT1385498E (pt) Ácidos gordos como factores de sobrevivência e activação de neutrófilos
HU203201B (en) Process for producing antitumoural pharmaceutical composition having synergetic effect
US4851435A (en) Antiviral and antitumor xanthate pharmaceutical compositions
EP1156797B1 (en) Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
KR100528815B1 (ko) 장쇄 알코올, 알칸, 지방산 및 아미드로 바이러스를 억제하는 방법
LT3197B (en) Use of quinones in the treatmet of cancer or aids
CA2066155A1 (en) Antiviral agent for human immunodeficiency virus
JP2724711B2 (ja) 医薬品生成物
JPS6328045B2 (es)
HU197212B (en) Process for producing pharmaceuticals with antiviral and antitumour effect
JP3176615B2 (ja) 乾癬症の局所治療剤及びその製法
DE3625948C2 (es)
JP2659428B2 (ja) テルルおよびセレン誘導体の複合体
KR970003049B1 (ko) 혈소판감소증 예방 및 치료제
WO1991004047A1 (en) Synergistic effect of human recombinant interferon-beta on halogenated pyrimidines
JPH07179347A (ja) 抗ウイルス組成物
Parab Hydroxyurea: Occurrence, Uses and Side Effects
JP2836797B2 (ja) 血小板減少症およびまたは白血球減少症治療剤
CA2052686A1 (en) Use of a retinoid
JPH07165577A (ja) ３ーオキシゲルミルプロピオン酸化合物並びに該化合物を主成分とする肝障害の予防及び治療剤
JPH01104009A (ja) 抗腫瘍剤
GB2324242A (en) Medicaments for treating viral infections
JPH07165576A (ja) ３ーオキシゲルミルプロピオン酸化合物を主成分とするｃ型ウイルス性肝炎の予防及び治療剤

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HPC4 Succession in title of patentee

Owner name: CT-HOLDING SA, CH

HMM4 Cancellation of final prot. due to non-payment of fee